CTI BioPharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is July - June.

Millions GBP. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Aug '25 Aug 1, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2019 - 2020
Market Capitalization	25	17	106	78	780	315	Upgrade
Market Cap Growth	129.87%	-83.91%	34.40%	-89.93%	147.61%	95.05%	Upgrade
Enterprise Value	24	21	88	54	729	301	Upgrade
Last Close Price	0.07	0.11	1.13	1.05	10.80	5.30	Upgrade
PS Ratio	10.75	9.38	39.40	32.12	722.27	-	Upgrade
PB Ratio	-22.72	-2.73	19.24	3.12	15.07	24.50	Upgrade
P/TBV Ratio	-	-	19.24	3.12	15.07	24.50	Upgrade
EV/Sales Ratio	10.25	11.44	32.94	22.04	675.32	-	Upgrade
Debt / Equity Ratio	-5.99	-1.09	1.74	0.40	-	0.02	Upgrade
Asset Turnover	0.26	0.12	0.08	0.05	0.03	-	Upgrade
Quick Ratio	2.20	0.47	1.58	3.59	9.31	4.34	Upgrade
Current Ratio	2.43	0.53	1.67	3.80	9.46	4.51	Upgrade
Return on Equity (ROE)	-	-	-242.76%	-88.72%	-80.88%	-80.48%	Upgrade
Return on Assets (ROA)	-128.10%	-93.54%	-65.43%	-51.79%	-41.33%	-42.16%	Upgrade
Return on Capital (ROIC)	-395.18%	-182.66%	-85.11%	-58.23%	-46.91%	-52.16%	Upgrade
Earnings Yield	-90.54%	-155.90%	-34.02%	-47.47%	-3.23%	-2.53%	Upgrade
FCF Yield	-86.37%	-140.33%	-25.42%	-48.73%	-2.71%	-2.65%	Upgrade
Buyback Yield / Dilution	-39.71%	-31.59%	-11.34%	-3.29%	-21.00%	-38.81%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.